About Index Trending news
Analyze
Pricing
Armune BioScience

Armune BioScience

Armune BioScience

Developed the technology APIFINY®—a prostate-cancer-specific non-PSA blood test that may improve decision making when selecting men for prostate biopsies.
I work here Suggest edits
More info

Elsewhere

Companies in the same industry

DxUpClose DxUpClose Cardia Cardia Embera NeuroTherapeutics Embera NeuroTherapeutics Theranica Theranica Zhejiang POCTech Corporation Zhejiang POCTech Corporation Kineta, Inc Kineta, Inc ResMed ResMed Alcon Alcon CEI GateWay CEI GateWay Avails Medical, Inc. Avails Medical, Inc.

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5
Add info
Add round
07 Sep 2016
$5,000,000
Venture capital (Series A)
Grand Angels Venture Fund II

Armune BioScience Closes $5M Series A Funding

FinSMEs
12 Jul 2016
$9,710,000
Venture capital (Series A)
Maverick Capital

Medical diagnostics startup secures $9M in funding

grbj
+2
20 Jan 2015
$3,537,583
Venture capital
22 Dec 2010
$250,000
Debt financing
25 Aug 2008
Venture capital